ArticleRSC advances2018
Correction: A microRNA-4516 inhibitor sensitizes chemo-resistant gastric cancer cells to chemotherapy by upregulating ING4.
Jun-Bao Liu, Dan Chen, Hai-Xia Liu, Huan-Huan Sha, Dan Song, Ting-Ting Bao, Jian-Wei Lu, Chen Yu
Abstract readPublished Erratum
In one paragraphArticle in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
8 authors.
Jun-Bao LiuTraditional Chinese Medicine Department, People's Hospital of Henan Province, People's Hospital of Zhengzhou University Zhengzhou Henan 450003 China.
Dan ChenResearch Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University Nanjing Jiang Su 210000 China.
Hai-Xia LiuEmergency Department, The Second Affiliated Hospital of Nanjing University of Chinese Medicine Nanjing Jiang Su 210017 China.
Huan-Huan ShaResearch Center of Clinical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University Nanjing Jiang Su 210000 China.
Dan SongDepartment of Radiotherapy, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University Nanjing Jiang Su 210000 China.
Ting-Ting BaoDepartment of Integrated TCM & Western Medicine, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University Nanjing Jiang Su 210000 China 41186709@qq.com.
Jian-Wei LuDepartment of Medicine, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University Nanjing Jiang Su 210000 China.
Chen YuDepartment of Integrated TCM & Western Medicine, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University Nanjing Jiang Su 210000 China 41186709@qq.com.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
[This corrects the article DOI: 10.1039/C8RA06419A.].
Identifiers
PMID35560569
PMCPMC9090929
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390